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provide new clinically useful information on the time course of im-
provements in cognitive/memory function and brain morphological
changes in OSA patients treated with CPAP. The study examined the
impact of CPAP on cognitive/memory function and brain morphology
in a relatively large group of 55 patients using a randomized parallelObstructive sleep apnea (OSA) is the most common respiratory
sleep disorder with recent estimates reporting a signiﬁcant rise in OSA
prevalence to over 20% of the middle-aged population (Heinzer et al.,
2015; Adams et al., 2012). OSA has been linked with excessive
day time sleepiness and neurobehavioral abnormalities including atten-
tion/vigilance dysfunction and memory impairments. These abnormal-
ities potentially contribute to elevated risk of road/work accidents and
earlier onset of neurological disorders (Beebe et al., 2003; Tregear
et al., 2009; Rosenzweig et al., 2015). Numerous studies report impair-
ments in brain oxygenation and morphology in OSA patients, which
may underpin the neurobehavioral impairments often observed in
these patients (Torelli et al., 2011).
Despite the considerable neurobehavioral sequel associated with
OSA, there is growing recognition that only a sub-set of at risk patients
are negatively affected. There is signiﬁcant disease heterogeneity in
daytime function between individual patients which also varies across
cognitive domains. For example, clinically, some patients may report
signiﬁcant daytime sleepiness and display clear vigilance/memory
impairments, while others do not show obvious daytime neurobehav-
ioral abnormalities. Similarly, response to treatment with continuous
positive airway pressure (CPAP), considered the ‘gold-standard’ in
treatingOSA, is also highly variable, oftenwith only partial effectiveness
in reversing neurobehavioral abnormalities, even in compliant patients
(Kushida et al., 2012; Antic et al., 2011). Thus, the relationship between
OSA, the brain and neurobehavioral function is complex and not well
understood highlighting the daily clinical challenge of identifying at
risk OSA patients, and knowing who, how, when and for how long one
should be treated to achieve effective therapy.om.2016.03.020.
. This is an open access article underIn this issue of EBioMedicine, Ivana Rosenzweig and colleagues
(Rosenzweig et al., 2016) have partly addressed this challenge and
group design. The novel aspect of the study was examining the impact
of 1 month of CPAP therapy which is shorter term compared with
existing literature where 3 or more months of CPAP have been previ-
ously used. Neurocognitive function focusing on memory and brain
imaging was assessed at baseline in all OSA patients and compared to
35 age and education matched controls, which is a strength of the
study. OSA patients were then randomized into two groups: 1) best
supportive care (BSC) group, which comprised education on sleep,
naps caffeine and sleep hygiene, or 2) BSC + CPAP group. All were
re-assessed at 1 month follow-up.
The main ﬁnding of the study was that CPAP therapy for one
month led to signiﬁcant improvements in brain morphology, daytime
sleepiness and verbal episodic memory function in the BSC + CPAP
group compared with the BSC only group. These early hypertrophic
morphological changes appeared to be speciﬁc to the right thalamus
and linked regions. Furthermore, interesting relationships were
observed between the morphological changes in the brainstem and
improvements in daytime sleepiness in the BSC + CPAP group.
These ﬁndings are important and suggest that brain plasticity is
initiated relatively early during CPAP therapy with rapid morphological
changes in at least some brain regions. These neuroplastic changes may
underlie improvements in at least some daytime abnormalities such as
daytime sleepiness. Although the sample was relatively large in this
study, the between subject design may have reduced the power to
detect differences between the interventions and explore relationships
between brain morphology and function. OSA is a complex disorder
with signiﬁcant heterogeneity in brain morphology, daytime functional
outcomes as well as cardio-metabolic outcomes. Greater recognition of
the complexity in sleepmedicine and other medical ﬁelds is driving the
move towards more personalized diagnosis and treatment approaches.
Towards this more research is needed, adopting within-group repeated
measures and randomized controlled cross-over designs to allowthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
24 A. Vakulin, D. Stevens / EBioMedicine 7 (2016) 23–24phenotyping and assessment of clinically useful neural markers
that underpin functional daytime impairments in OSA. This would
allow for early identiﬁcation of patient most at risk of functional neuro-
behavioral and memory impairments and those who respond
favorably/rapidly to therapy.
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